At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...

Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...

Vaccines are saving millions of lives world over, but in India, we continue to experience critical challenges in implementing ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products, Spikevax and mResvia.

Moderna, the bloodied Covid-era prizefighter of the healthcare sector, stumbles toward its next earnings report on Thursday ...

Huntington’s disease slows the cell’s protein factory, causing production line jams & toxicity. A faulty blueprint & missing ...